RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

@article{Schwaeble2005RGS2IA,
  title={RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.},
  author={J. Schwaeble and C. Choudhary and C. Thiede and L. Tickenbrock and B. Sargin and C. Steur and M. Rehage and A. Rudat and C. Brandts and W. Berdel and C. M{\"u}ller-Tidow and H. Serve},
  journal={Blood},
  year={2005},
  volume={105 5},
  pages={
          2107-14
        }
}
  • J. Schwaeble, C. Choudhary, +9 authors H. Serve
  • Published 2005
  • Biology, Medicine
  • Blood
  • Activating fetal liver tyrosine kinase 3 (Flt3) mutations represent the most common genetic aberrations in acute myeloid leukemia (AML). Most commonly, they occur as internal tandem duplications in the juxtamembrane domain (Flt3-ITD) that transform myeloid cells in vitro and in vivo and that induce aberrant signaling and biologic functions. We identified RGS2, a regulator of G-protein signaling, as a gene specifically repressed by Flt3-ITD. Here we demonstrate an important role of RGS2 in Flt3… CONTINUE READING
    75 Citations
    Mutant FLT3 signaling contributes to a block in myeloid differentiation
    • 32
    FLT3 inhibitors: clinical potential in acute myeloid leukemia
    • 17
    • PDF
    C/EBPα and MYB regulate FLT3 expression in AML
    • 22
    • PDF

    References

    SHOWING 1-10 OF 62 REFERENCES
    Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells
    • 169
    PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
    • 280
    • PDF
    PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model.
    • 182